We thank our Editorial Team, Associate Editors, and Board members for their services and support. Our two newest Associate Editors, Barbara De la Salle and Archana Agarwal, have now settled into the team and are working hard on your manuscripts.
The Journal has been online only from January 2023 and the print issue has been gradually terminated. For the convenience of authors, editors and publishers, the ISLH Educational Supplement is now a virtual issue. The flexible nature of this allows any manuscripts submitted late, or that are delayed in the reviewing, correction and editorial stages to be progressively added to the online supplement and viewed together in one place. The articles are also assigned to regular issues of the journal and appear throughout the year.
In June 2025, the journal migrated to the Research Exchange Platform. This provides a seamless transition from manuscript submission, through screening, editorial assessment, peer review and publication/production. Authors have given very positive feedback about the platform with submission becoming faster and more efficient. The manuscript handling and Editorial processing stages have not been without problems, which has sometimes caused unfortunate delays in manuscript handling, but Research Exchange is being continually developed and improved, with new features becoming available each month. So hopefully in the longer term, the manuscript turnaround times will become shorter. The number of manuscript submissions has been maintained and our acceptance rate has remained at approximately 21%. Manuscripts found to be scientifically sound, but unacceptable for IJLH (through being outside our scope, having insufficient novelty or for other reasons) are referred to other journals within the Wiley network (e.g., Health Science Reports, Clinical Case Reports and the Journal of Clinical Laboratory Analysis, Hematological Oncology, eJHaem, and Transfusion) to assist authors in getting their manuscript published with minimal reformatting.
The readership figures remain high (699 253 full text views), with the USA and China accounting for our highest readership. These two countries are also our top author submission countries. 181 articles were published in 2025. Our most recent impact factor (2024) was 2.3, marginally higher than for the previous year. ISLH Supplement review articles continue to feature in our top 10 most downloaded articles.
We have plans for Special Issues of the Journal covering specialist subject areas of topical interest. We have so far commissioned issues on Blood Doping in Sport and Haemostasis Tests in Low to Middle Income countries, each with their own Guest Editors.
Funding
The authors have nothing to report.
Conflicts of Interest
The authors declare no conflicts of interest.
Data Availability Statement
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
